IRF9 and peripheral arterial disease: MiR-93 has been shown to promote angiogenesis and reduce tissue loss in experimental models of peripheral arterial disease (PAD), which is because it promotes and sustains M2-like polarization even under M1-like polarizing settings by targeting interferon regulatory factor-9 to diminish IRG1-itaconic acid synthesis (88).